TCL Archive Facilities Survey Finrs $25 Million a Year for Five Years Needed From NCI By Year 1990 March 8, 1985
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Kennedy Bill Leaves National Cancer Act intact, Creates NIH Construction Authority, Senior Service April 1, 1988
TCL Archive In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care October 24, 1975
